BioSpace News Archive

Soleno Therapeutics, Inc. (“Soleno”) (NASDAQ: SLNO), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of rare diseases, today announced that Anish Bhatnagar, M.D., Chief Executive Officer, will participate in a fireside chat at Oppenheimer’s 33rd Annual Healthcare Conference on Tuesday, March 14, 2023 at 11:20 AM Eastern Time.

X4 Pharmaceuticals, Inc. (Nasdaq: XFOR), a leader in the discovery and development of novel small molecule therapeutics to benefit patients with diseases of the immune system, today announced that it will be reporting financial results for the fourth quarter and twelve months ended December 31, 2022 on March 21, 2023.

Onconova Therapeutics, Inc. (NASDAQ: ONTX), (“Onconova”) announced new preclinical data characterizing rigosertib’s mechanisms of action in a poster at the American Association for Cancer Research Special Conference on Targeting RAS (AACR Targeting RAS Conference).

Certara, Inc., a global leader in biosimulation, announced the release of Simcyp Simulator Version 22, which includes new capabilities and updated features to the Company’s population-based modeling and simulation platform.

Panbela Therapeutics, Inc. (Nasdaq: PBLA), a clinical stage company developing disruptive therapeutics for the treatment of patients with urgent unmet medical needs, today announced its first patient enrolled in South Korea for its ASPIRE global clinical trial in the first-line treatment of metastatic pancreatic cancer.

Orchestra BioMed Holdings, Inc. announced that company management will present and be available for one-on-one meetings at Oppenheimer’s 33rd Annual Healthcare Conference, which is taking place virtually from March 13-15, 2023, and the Barclays Global Healthcare Conference, which is taking place in Miami, FL, from March 14-16, 2023.

Indaptus Therapeutics, Inc. (Nasdaq: INDP, “Indaptus” or “the Company”) today announces the dosing of the first subject in INDP-D101.

AuraVax Therapeutics, Inc. announced the appointment of Joseph C. Sullivan as Chief Executive Officer.

Veru Inc. today announced that Mitchell Steiner, M.D., Chairman, President and Chief Executive Officer of Veru, will present at the upcoming virtual Oppenheimer 33rd Annual Healthcare Conference on Tuesday, March 14, 2023 at 12 pm ET.

IPA, an advanced biotherapeutic research and technology company, announced that it will host a conference call to discuss its quarterly results and recent business highlights for third quarter fiscal year 2023, on Thursday, March 16, 2023, at 10:30 am Eastern Time.